{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:09:38Z","timestamp":1786471778343,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_207687"],"award-info":[{"award-number":["320030_207687"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>SCORE2 estimates the 10-year risk of developing non-fatal and fatal cardiovascular disease (CVD), and it was designed for mostly Europeans. However, its transferability to non-European populations has not been extensively studied. The aim of this study was to evaluate the performance of the SCORE2 in ethnically and socioeconomically diverse populations, including those outside of Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We leveraged cohort studies from Mexico (N = 95,660, mean age 52.4 years, 32.6% men, mean follow-up 9.7 years), and Portugal (N = 1,216, 52.9 years, 36.9% men, 8.8 years follow-up). SCORE2 has differentially classified frequency of CVD events across levels of risk severity, ranging from 0.7\u20131.0% CVD events among those with low-moderate risk-profiles, vs. 6.6\u20139.0% among those with high risk-profiles, respectively. The area under the receiver operating curve (AROC) was 0.762 in Mexico and 0.718 in Portugal. Sensitivities (95% CI) were 85.7 (84.2\u201387.2) and 95.0 (86.1\u201399.0), and specificities were 42.8 (42.5\u201343.1) and 24.3 (21.9\u201326.9) for Mexico and Portugal, respectively. In all cases, the positive predictive values were below 7%, whereas the negative predictive values were all above 98%. Harrell\u2019s C were 0.717 and 0.692, and Brier\u2019s scores were 0.022 and 0.052 for Mexico and Portugal, respectively. In Mexico, SCORE2 showed good calibration, with a slight overestimation in the higher-risk categories. In Portugal, overestimation in higher-risk categories was more substantial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SCORE2 estimates modest to acceptable performance for predicting the 10-year CVD in Mexicans but performed less favourably in the Portuguese cohort, indicating a need for recalibration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcag009","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:41:53Z","timestamp":1769258513000},"page":"863-871","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the European SCORE2 algorithm in one European and one Latin-American cohort studies with contrasting populations"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-3701","authenticated-orcid":false,"given":"Ko Ko","family":"Maung","sequence":"first","affiliation":[{"name":"Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV), University of Lausanne , Lausanne ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-5905","authenticated-orcid":false,"given":"Eirini","family":"Trichia","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-6571","authenticated-orcid":false,"given":"Henrique","family":"Barros","sequence":"additional","affiliation":[{"name":"Epidemiology Research Unit (EPIUnit), Instituto de Sa\u00fade P\u00fablica da Universidade do Porto (ISPUP) , Porto ,","place":["Portugal"]},{"name":"Laborat\u00f3rio para a Investiga\u00e7\u00e3o Integrativa e Translacional em Sa\u00fade Populacional (ITR), Instituto de Sa\u00fade P\u00fablica da Universidade do Porto (ISPUP) , Porto ,","place":["Portugal"]},{"name":"Departamento de Ci\u00eancias da Sa\u00fade P\u00fablica e Forenses e Educa\u00e7\u00e3o M\u00e9dica, Faculdade de Medicina, Universidade do Porto (FMUP) , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6698-1257","authenticated-orcid":false,"given":"Vlada","family":"Hanchar","sequence":"additional","affiliation":[{"name":"Epidemiology Research Unit (EPIUnit), Instituto de Sa\u00fade P\u00fablica da Universidade do Porto (ISPUP) , Porto ,","place":["Portugal"]},{"name":"Laborat\u00f3rio para a Investiga\u00e7\u00e3o Integrativa e Translacional em Sa\u00fade Populacional (ITR), Instituto de Sa\u00fade P\u00fablica da Universidade do Porto (ISPUP) , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Alegre-D\u00edaz","sequence":"additional","affiliation":[{"name":"Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]},{"name":"School of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-3317","authenticated-orcid":false,"given":"Jaime","family":"Berumen","sequence":"additional","affiliation":[{"name":"Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]},{"name":"School of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-9507","authenticated-orcid":false,"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[{"name":"Escuela de Medicina y Ciencias de la Salud, Instituto Tecnol\u00f3gico y de Estudios Superiores de Monterrey , Monterrey ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tapia-Conyer","sequence":"additional","affiliation":[{"name":"Experimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]},{"name":"School of Medicine, National Autonomous University of Mexico , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-2220","authenticated-orcid":false,"given":"Louisa","family":"Gnatiuc Friedrichs","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-8500","authenticated-orcid":false,"given":"Pedro","family":"Marques-Vidal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV), University of Lausanne , Lausanne ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2026081102573892000_qcag009-B1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.00000000000010","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2026081102573892000_qcag009-B2","author":"British Heart Foundation","year":"2023"},{"key":"2026081102573892000_qcag009-B3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat Med"},{"key":"2026081102573892000_qcag009-B4","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European union: a population-based cost study","volume":"44","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081102573892000_qcag009-B5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archinternmed.2011.1484","article-title":"Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials","volume":"172","author":"Stergiopoulos","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026081102573892000_qcag009-B6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.0213","article-title":"Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","year":"2016","journal-title":"Circulation"},{"key":"2026081102573892000_qcag009-B7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081102573892000_qcag009-B8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ije\/dyl042","article-title":"Cohort profile: the Mexico city prospective study","volume":"35","author":"Tapia-Conyer","year":"2006","journal-title":"Int J Epidemiol"},{"key":"2026081102573892000_qcag009-B9","author":"ThemeZaa"},{"key":"2026081102573892000_qcag009-B10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.annepidem.2003.09.013","article-title":"Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction","volume":"14","author":"Ramos","year":"2004","journal-title":"Ann Epidemiol"},{"key":"2026081102573892000_qcag009-B11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026081102573892000_qcag009-B12","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-023-06595-3","article-title":"Genotyping, sequencing and analysis of 140,000 adults from Mexico city","volume":"622","author":"Ziyatdinov","year":"2023","journal-title":"Nature"},{"key":"2026081102573892000_qcag009-B13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurjpc\/zwad012","article-title":"Combining European and U.S. Risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study","volume":"30","author":"de La Harpe","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026081102573892000_qcag009-B14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurjpc\/zwab201","article-title":"Cardiovascular risk assessment in people living with HIV compared to the general population","volume":"29","author":"Delabays","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026081102573892000_qcag009-B15","author":"World Health Organization","year":"2025"},{"key":"2026081102573892000_qcag009-B16","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081102573892000_qcag009-B17","first-page":"437","article-title":"Validation of the SCORE2 risk prediction algorithm in a Portuguese population: a new model to estimate 10-year cardiovascular disease incidence in Europe","volume":"43","author":"Temtema","year":"2024","journal-title":"ScienceDirect"},{"key":"2026081102573892000_qcag009-B18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nut.2019.03.005","article-title":"Adherence to a Mediterranean Dietary Pattern status and associated factors among Portuguese older adults: Results from the Nutrition UP 65 cross-sectional study","volume":"65","author":"Teixeira","year":"2019","journal-title":"Nutrition"},{"key":"2026081102573892000_qcag009-B19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.24875\/GMM.M24000837","article-title":"The burden of cardiovascular disease in Mexico 1990\u20132021. Summary of the Global Burden of Disease 2021 study","volume":"159","author":"Fajardo-Dolci","year":"2024","journal-title":"Gaceta M\u00e9dica de M\u00e9xico"},{"key":"2026081102573892000_qcag009-B20","doi-asserted-by":"crossref","first-page":"e002762","DOI":"10.1136\/openhrt-2024-002762","article-title":"Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-brasil study","volume":"11","author":"Camargos","year":"2024","journal-title":"Open Heart"},{"key":"2026081102573892000_qcag009-B21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/eurjpc\/zwae242","article-title":"External validation and comparison of six cardiovascular risk prediction models in the Prospective Urban Rural Epidemiology (PURE)-Colombia study","volume":"32","author":"Lopez-Lopez","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026081102573892000_qcag009-B22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"2026081102573892000_qcag009-B23","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/sim.9025","article-title":"Minimum sample size for external validation of a clinical prediction model with a binary outcome","volume":"40","author":"Riley","year":"2021","journal-title":"Stat Med"},{"key":"2026081102573892000_qcag009-B24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1474515118783157","article-title":"Factors associated with non-participation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies","volume":"18","author":"Resurrecci\u00f3n","year":"2019","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026081102573892000_qcag009-B25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ypmed.2015.04.009","article-title":"Smoking and cardiac rehabilitation participation: associations with referral, attendance and adherence","volume":"80","author":"Gaalema","year":"2015","journal-title":"Prev Med"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag009\/66592350\/qcag009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/5\/863\/66592350\/qcag009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/5\/863\/66592350\/qcag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:57:47Z","timestamp":1786431467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/12\/5\/863\/8442459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcag009","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,1,27]]}}}